Synthesis and biologic activities on 1-{1-[2-(3,4-dimethoxy) phenylethyl]-5-cyano-6-methyl-uracil-3yl}-3-substituted amino-2-propanol compounds

Journal of China Pharmaceutical University

Volumn 34, Issue 5, 2003, Pages 396-399

  Zhang, Jun Qi ^a   Wang, Li Chen ^a   Jiang, Zhen Zhou ^a   Lin, Mi ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

1 1 2 (3,4 dimethoxy) phenylethyl 5 cyano 6 methyl uracil 3yl 3 substituted amino 2 proanol compounds; CHF; adrenergic receptor antagonist; Positive isotropic action

Indexed keywords

1 [ 1 [ 2 ( 3,4 DIMETHOXY)PHENYLETHYL] 5 CYANO 6 METHYL URACIL 3YL ]AMINO 2 PROPANOL; 1 [ 2 (3,4 DIMETHOXY)PHENYLETHYL] 5 CYANO 6 METHYL URACIL; PROPRANOLOL DERIVATIVE; UNCLASSIFIED DRUG; URACIL DERIVATIVE;

ARTICLE; BIOLOGICAL ACTIVITY; CHEMICAL STRUCTURE; INFRARED RADIATION; SYNTHESIS;

EID: 29744456582     PISSN: 10005048     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Patterson JH, Adams KF JR, et al. Understanding the Management of Heart Failure[J]. Pharmacotherapy, 2000 20(5):493-494.
2. Chin J Cardiol, 2002,30(1):7-23.
3. Dai GZ. Chin J Cardiol, 2002,30(1):1.
4. Wang LC, Yu LL, Huang JZ. J China Pharm Univ, 1990,21(6):325-328.
5. Wang LC, Ren JZ, Liu BL. J China Pharm Univ, 1996,27(10):577-580.
6. Wang LC, Liu BL, Ren JZ. J China Pharm Univ, 1998,29(4):251-254.
7. Wang LC, Zhang YY, Zhang LY. J China Pharm Univ, 2001,32(6): 408-411.